Martin Mackay

Type: Person
Name: Martin Mackay
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Heroic boy, 11, saves mum and baby brother from 'berserk' dog which bit hole in his face

Jack Mackay put his body on the line and was left with a "hole" bitten in his face when a vicious bull mastiff slipped its owners' lead.Around 30 children who were playing nearby ran away but the dog spotted Jack's mother Lacy Farlam, 29, who was holding ... [Published Daily Express - Apr 17 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 2 reports

Pictured: Heroic 11-year-old boy who saved his mum and baby brother from 'berserk' dog attack

Brave Jack Mackay jumped in the path of the deranged dog when it tried to attack mum Lacy - suffering severe injuries to his head and arm in the processView galleryCascadeJack MackayView galleryA heroic boy who saved his mum and baby brother from a "berserk" ... [Published Mirror.co.uk - Apr 17 2014]
First reported Mar 12 2014 - Updated Mar 12 2014 - 1 reports

European Commission Grants Orphan Drug Designation to Soliris Eculizumab for Prevention of Delayed Graft Function DGF after Solid Organ...

European Commission Grants Orphan Drug Designation to Soliris Eculizumab for Prevention of Delayed Graft Function DGF after Solid Organ TransplantationBy a News Reporter-Staff News Editor at Biotech Week Alexion Pharmaceuticals (Nasdaq:ALXN) announced ... [Published Pharmacy Choice - Mar 12 2014]
First reported Feb 15 2014 - Updated Feb 15 2014 - 1 reports

Prothelia, University of Nevada sign agreements with Alexion to develop Laminin-111

Prothelia Incorporated, a privately held biotechnology company, and University of Nevada, Reno have entered into strategic agreements with Alexion for the development of Laminin-111, a patented experimental protein replacement therapy for merosin-deficient ... [Published PharmaBiz - Feb 15 2014]
First reported Feb 13 2014 - Updated Feb 14 2014 - 1 reports

Prothelia and the University of Nevada, Reno Enter Into Exclusive Strategic Agreements with Alexion for Catastrophic, Ultra-Rare Neuromuscular Disorder

MILFORD, Mass.The three parties have entered into a binding agreement wherein Alexion has an exclusive option to acquire privately-held Prothelia and license Laminin-111 directly from the University of Nevada, Reno"This partnership with Alexion represents ... [Published PR Newswire - Feb 13 2014]
First reported Jan 22 2014 - Updated Jan 23 2014 - 1 reports

US FDA grants Alexion' Soliris orphan drug status to prevent kidney transplant rejection

The US Food and Drug Administration (FDA) has granted orphan drug designation Alexion Pharmaceuticals for Soliris (eculizumab) for the prevention of delayed graft function (DGF) in renal transplant patients.The company said that DGF is an early and serious ... [Published Pharmaceutical Business Review - Jan 22 2014]
First reported Oct 28 2013 - Updated Oct 28 2013 - 1 reports

Alexion's cPMP replacement therapy gets US FDA breakthrough therapy status to treat patients with MoCD Type A

Alexion Pharma International Sàrl, a subsidiary of Alexion Pharmaceuticals, Inc. has received a breakthrough therapy designation from the US Food and Drug Administration (FDA) for cyclic pyranopterin monophosphate (cPMP, or ALXN1101), an enzyme co-factor ... [Published PharmaBiz - Oct 28 2013]

More Content

All (10) | News (9) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Heroic boy, 11, saves mum and baby brother from... [Published Daily Express - Apr 17 2014]
Pictured: Heroic 11-year-old boy who saved his ... [Published Mirror.co.uk - Apr 17 2014]
Hero schoolboy, 11, suffers horrific facial inj... [Published Mail Online UK - Apr 17 2014]
'Berserk' Eltham dog bites hole in boy's face a... [Published News Shopper - Apr 16 2014]
European Commission Grants Orphan Drug Designat... [Published Pharmacy Choice - Mar 12 2014]
Prothelia, University of Nevada sign agreements... [Published PharmaBiz - Feb 15 2014]
Prothelia and the University of Nevada, Reno En... [Published PR Newswire - Feb 13 2014]
US FDA grants Alexion' Soliris orphan drug stat... [Published Pharmaceutical Business Review - Jan 22 2014]
Alexion's cPMP replacement therapy gets US FDA ... [Published PharmaBiz - Oct 28 2013]
Alexion obtains FDA breakthrough therapy status... [Published Pharmaceutical Technology - Oct 25 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.